Lupin launches digital asthma educator platform for guiding patients on use of inhalers
New Delhi: Drug major Lupin on Monday announced the launch of its digital asthma educator platform to guide patients on the correct technique of using inhalers.
The new platform is the latest initiative under Lupin''s long running umbrella programme, Joint Airways Initiative (JAI), for patients suffering from respiratory ailments.
Lupin has launched its digital asthma educator platform. The platform guides asthma patients on the correct technique of using inhalers, the company said in a regulatory filing.
Lupin said, according to estimates, India has nearly 35 million people living with asthma, including children.
While there is no cure for asthma, it is manageable with proper treatment, vigilance, drug adherence and regular medical checks, thus enabling patients to lead a normal life, the company added.
Read also: Lupin launches Arformoterol Tartrate Inhalation Solution in US
Rajeev Sibal, President - India Region Formulations, Lupin said, "Studies indicate that nearly 90 per cent of patients don''t use their inhalers correctly. This can have multiple implications such as developing uncontrolled symptoms, a higher rate of asthma attacks or even flare-ups. We believe this platform would assist healthcare professionals in significantly helping their patients understand correct inhalation technique and better manage their ailment."
Lupin said it will undertake a pan India integrated marketing campaign including social media and radio channels.
Read also: Lupin to introduce healthcare space for doctors, patients with Lupin Digital Health in India
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.